13 July 2026

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

13 July 2026 | n=21

  1. Nawfal ES, Sheehan DM, Ibanez G, Hayes T, et al.
    HIV-related stigma, antiretroviral adherence, and viral suppression among women with HIV: the role of anxiety and patient-provider relationship.
    AIDS 2026.

  2. Bobadilla R, Tenenbaum TL, Vanpouille C, Wells A, et al.
    Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapy.
    AIDS 2026.

  3. Timiryasova A, Greenberg L, Domingo P, Tarr PE, et al.
    CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.
    AIDS 2026.

  4. Benlarbi M, Andalibi MS, Belanger E, Tauzin A, et al.
    HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.
    AIDS 2026.

  5. Brouillette MJ, Scott SC, Harris M, Thomas R, et al.
    Vascular risk drives cognitive decline over 10 years in people aging with well-controlled HIV.
    AIDS 2026.

  6. Li J, Zhou M, Guo H, Huang L, et al.
    Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.
    AIDS Res Hum Retroviruses 2026.

  7. Millard PS.
    In HIV-1, bictegravir-lenacapavir was noninferior to continued complex regimens for maintaining viral suppression at 48 wk.
    Ann Intern Med 2026.

  8. Jones T, Lefebvre M, Reyes O, Dalton J, et al.
    Fever in a Man with Uncontrolled HIV.
    Clin Infect Dis 2026;82:1091-1095.

  9. Chakrawarti A, Cromarty RT, Basting CM, Anderson J, et al.
    Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.
    Clin Infect Dis 2026.

  10. Mazzitelli M, Parczewski M, Burger D, Wensing A, et al.
    Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.
    Clin Infect Dis 2026.

  11. Melendez JH, Onzia AA, Mande E, Tirado AM, et al.
    Pharyngeal gonorrhea in Ugandan men with urogenital gonorrhea: differences in antimicrobial resistance and strain types between anatomical sites.
    J Infect Dis 2026.

  12. Arrambide CAJ, Karampoor S, Abdelrahim IM, Maloletneva NV, et al.
    Hijacking the Host: Post-Translational Modifications as Molecular Switches in HIV Persistence and Immune Evasion.
    J Med Virol 2026;98:e71048.

  13. Ma J, Wang X, Sarkar P, He J, et al.
    JQKD82 Inhibits HIV Infection of Macrophages Through Blocking Viral Entry and Enhancing Antiviral ISG Responses.
    J Med Virol 2026;98:e71043.

  14. Gosset PE, Margueron-Sentis C, Ramiere C, Zoulim F, et al.
    Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study.
    J Med Virol 2026;98:e71050.

  15. Gan L, Xie X, Fu Y, Yang X, et al.
    Metabolic and Immunological Trajectories and Virological Outcomes of Ainuovirine-Based Antiretroviral Therapy: A 48-Week Longitudinal Cohort Study in Treatment-Naive Adults.
    J Med Virol 2026;98:e71038.

  16. Omondi FH, Shahid A, Kinloch NN, Dong W, et al.
    HIV superinfection reveals sequential reservoir reactivation and immune-driven rebound dynamics.
    J Virol 2026.

  17. The Lancet.
    Ending HIV: a reality check.
    Lancet 2026;408:93.

  18. Theodore DA, Mayer BT, Rolle CP, DeJesus E, et al.
    Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.
    Nat Med 2026.

  19. Seib KL, Donovan B, Jin F, Thng C, et al.
    Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection.
    N Engl J Med 2026.

  20. Terzopoulos N, Tiplady O, Pan Q, Liang C, et al.
    Development of a virus particle fusion assay to study and target virus entry.
    Virology 2026;623:111025.

  21. Nakamura Y, Ahagon-Edamura A, Koga R, Shimagaki K, et al.
    Regulation of HIV-2 Vpx/Vpr expression by the poly-proline motif: Enhancement of protein dimerization and translation.
    Virology 2026;623:111016.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

27 July 2026

20 July 2026

13 July 2026

06 July 2026

29 June 2026


13 July 2026

Multidisciplinary Journal Club

    No data available 2026-07-13.


Privacy Policy